Edwards Lifesciences (EW) Free Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Edwards Lifesciences (EW) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 178.48 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 124.33 Bn | 119.11 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 118.50 Bn | 109.68 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 106.32 Bn | 102.85 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.81 Bn | 66.27 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 34.03 Bn | 32.57 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.84% |
| Mar 31, 2026 | -109.40% |
| Dec 31, 2025 | 299.38% |
| Sep 30, 2025 | 72.12% |
| Jun 30, 2025 | -15.80% |
| Mar 31, 2025 | 288.89% |
| Dec 31, 2024 | -467.08% |
| Sep 30, 2024 | -15.81% |
| Jun 30, 2024 | 2,100.70% |
| Mar 31, 2024 | -147.03% |
| Dec 31, 2023 | -77.42% |
| Sep 30, 2023 | 42.48% |
| Jun 30, 2023 | -104.95% |
| Mar 31, 2023 | 14.51% |
| Dec 31, 2022 | -24.63% |
| Sep 30, 2022 | -46.94% |
| Jun 30, 2022 | -36.71% |
| Mar 31, 2022 | 13.42% |
| Dec 31, 2021 | -0.98% |
| Sep 30, 2021 | 317.73% |